Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Rankning i aktier #40870
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Aktiekurs
$0.02765
Senast synkroniserad: 2024-12-23
Marknadsvärde
$69.04K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Histogen Inc. (HSTO)

Kategori

Historik för aktiesplit för Histogen Inc. (HSTO)
Aktien Histogen Inc. (symbol: HSTO) har genomgått totalt 2 aktiesplitar.
Den senaste spliten skedde den Jun 03, 2022.
En HSTO-aktie köpt före May 27, 2020 motsvarar nu 0.005 HSTO-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2022-06-03 1:20 x0.05 x0.005
2020-05-27 1:10 x0.1 x0.1
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE